Type 2 Diabetes Mellitus In Nepal from 2000 to 2020: A Systematic Review and Meta-analysis
Overview
Science
Authors
Affiliations
To evaluate the prevalence and risk factors of type 2 diabetes mellitus (T2DM) from 2000-2020 in various parts of Nepal. PubMed, Embase, Scopus, and Google Scholar were searched using the appropriate keywords. All Nepalese studies mentioning the prevalence of T2DM and/or details such as risk factors were included. Studies were screened using Covidence. Two reviewers independently selected studies based on the inclusion criteria. Meta-analysis was conducted using Comprehensive Meta-Analysis Software v.3. A total of 15 studies met the inclusion criteria. The prevalence of T2DM, pre-diabetes, and impaired glucose tolerance in Nepal in the last two decades was 10% (CI, 7.1%- 13.9%), 19.4% (CI, 11.2%- 31.3%), and 11.0% (CI, 4.3%- 25.4%) respectively. The prevalence of T2DM in the year 2010-15 was 7.75% (CI, 3.67-15.61), and it increased to 11.24% between 2015-2020 (CI, 7.89-15.77). There were 2.19 times higher odds of having T2DM if the body mass index was ≥24.9 kg/m . Analysis showed normal waist circumference, normal blood pressure, and no history of T2DM in a family has 64.1%, 62.1%, and 67.3% lower odds of having T2DM, respectively. The prevalence of T2DM, pre-diabetes, and impaired glucose tolerance in Nepal was estimated to be 10%, 19.4%, and 11% respectively.
Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal.
Dahal P, Vandelanotte C, Rawal L, Mahumud R, Paudel G, Lloyd M BMC Med. 2025; 23(1):153.
PMID: 40069657 PMC: 11900644. DOI: 10.1186/s12916-025-03981-8.
Pandit A, Sapkota B, Poudel N, Karki R, Poudel B, Lamichhane R PLoS One. 2025; 20(2):e0313755.
PMID: 40019907 PMC: 11870340. DOI: 10.1371/journal.pone.0313755.
Dahal P, Ademi Z, Rawal L, Mahumud R, Paudel G, Karmacharya B Glob Health Res Policy. 2024; 9(1):52.
PMID: 39690410 PMC: 11650842. DOI: 10.1186/s41256-024-00364-z.
Shrestha R, Aryal A, Khatiwada A, Dhungana S, Shrestha S PLoS One. 2024; 19(12):e0310706.
PMID: 39636918 PMC: 11620429. DOI: 10.1371/journal.pone.0310706.
In Vitro and in Silico Analysis of α -Amylase Inhibitory Activity of Ethanolic Extract of Leaves.
Yadav C, Kc S, Thapa S Glob Adv Integr Med Health. 2024; 13:27536130241270621.
PMID: 39219710 PMC: 11365037. DOI: 10.1177/27536130241270621.